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Exit from Exit: Resetting the Cell Cycle
through Amn1 Inhibition of G Protein Signaling
is the conversion of a cell from the mitotic state with
high Cdk1 activity, to a non-mitotic state in which Cdk1
activity is extinguished through a variety of mechanisms.
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Exit from mitosis after chromosome segregation is trig-1Verna and Marrs McLean Department of
gered by the conversion of Tem1, a spindle pole bodyBiochemistry and Molecular Biology
located G protein, from the GDP bound form to the2 Howard Hughes Medical Institute
GTP bound form (Shirayama et al., 1994; Morgan, 1999).3 Department of Molecular Physiology
When cells undergo anaphase, the spindle pole bodyand Biophysics
enters the daughter cell where the guanine nucleo-4 Department of Molecular and Human Genetics
tide exchange factor (GEF) Lte1 is localized (Bardin etBaylor College of Medicine
al., 2000; Pereira et al., 2000). Lte1 then convertsHouston, Texas 77030
Tem1(GDP) to the active Tem1(GTP) form. Tem1 then
binds to and activates the Cdc15 kinase and the mitotic
exit network, MEN. MEN activation results in the releaseSummary
of Cdc14 from its nucleolar localized inhibitor Cfi1/Net1
and activation of Cdc14 as a phosphatase (Shou et al.,In S. cerevisiae cells undergoing anaphase, a ras-related
1999; Visintin et al., 1999). Cdc14 can remove inhibitoryGTPase, Tem1, is located on the spindle pole body
phosphorylation of Cdc15 in a positive feedback loopthat enters the daughter cell and activates a signal
(Jaspersen and Morgan, 2000). A second pathway calledtransduction pathway, MEN, to allow mitotic exit. MEN
FEAR also contributes to the initial release of Cdc14activation must be reversed after mitotic exit to reset
from the nucleolus during early anaphase and facilitatesthe cell cycle in G1. We find that daughter cells activate
Cdc15 dephosphorylation and MEN activation (Steg-an Antagonist of MEN pathway (AMEN) in part through
meier et al., 2002).induction of the Amn1 protein that binds directly to
Cdc14 acts to inhibit Cdk1 activity in three ways (Visin-Tem1 and prevents its association with its target ki-
tin et al., 1998). First, it promotes destruction of B typenase Cdc15. Failure of Amn1 function results in defects
cyclins by activation of the anaphase promoting com-of both the spindle assembly and nuclear orientation
plex/cyclosome (APC/C), the E3 ubiquitin ligase respon-checkpoints and delays turning off Cdc14 in G1. Thus,
sible for cyclin ubquitination. Cdc14 activates the Cdh1Amn1 is part of a daughter-specific switch that helps
specificity factor, which then activates APCCdh1. Sec-cells exit from mitotic exit and reset the cell cycle.
ondly, it both stabilizes and induces the transcription of
the Cdk1 inhibitor Sic1 (Knapp et al., 1996, Visintin et al.,Introduction
1998). Third, the phosphatase activity of Cdc14 directly
reverses Cdk1 phosphorylation of substrates (Visintin
The cell cycle is a series of highly ordered processes that
et al., 1998). The culmination of these events is the es-
culminate in the duplication of a cell. As cells progress
tablishment of a stable state in which Cdk1 activity is
through the cycle, they undergo several discrete transi- off, allowing the reversal of mitotic events and the pro-
tions. A cell cycle transition is a unidirectional change motion of cytokinesis.
of state in which a cell that was performing a defined The failure to turn off mitotic exit is deleterious to cell
set of processes alters its state to perform a different cycle progression in the next cycle (Visintin et al., 1998).
set of processes. A particular cell cycle state exists in How does the MEN pathway turn itself off to facilitate
a metastable environment in which a self-perpetuating future G1 events? One mechanism is the destruction
series of biochemical reactions occur. As these reac- of a key initiator of MEN, Cdc5, via APCCdh1-directed
tions achieve the selected goal of that cell cycle state, ubiquitinlyation. Cdc5 must be resynthesized in the next
a new biochemical state begins to emerge and alters cycle to reactivate the MEN. While required for entry
the balance of regulators to initiate a cell cycle transition into mitotic exit, it is not clear whether Cdc5 is required
to a new metastable state. Cell cycle transitions have a for maintenance of the mitotic exit state. A second
number of general properties. As they proceed, they mechanism is the reactivation of the Tem1 inhibitor
tend to turn off processes in the current state and self Bfa1/Bub2, which is inhibited by Cdc5 phosphorylation.
reinforce the regulatory environment of the new state As cells exit mitosis and return to G1, Bfa1/Bub2 is
through positive feedback loops. In addition, they typi- dephosphorylated in a MEN-dependent fashion (Hu et
cally set in motion the events that will eventually contrib- al., 2001; Lee et al., 2001), possibly by Cdc14 itself (Per-
ute to the next cell cycle transition, effectively sowing eira et al., 2002). These events are reversals of pro-
the seeds of their own destruction through a slow or mitotic exit events. In this study, we describe a daughter
event-dependent negative feedback loop. cell-specific protein, Amn1, induced by the MEN that
Mitotic exit is an example of a cell cycle transition actively interferes with MEN function to turn off the mi-
that sets up a self-reinforcing mechanism. Mitotic exit totic exit state. Amn1 protein is induced only after activa-
tion of mitotic exit and acts to inhibit mitotic exit by
binding to Tem1 and facilitating inactivation of Cdc14.*Correspondence: selledge@bcm.tmc.edu
After cells re-establish the active Cdk1 state, Amn1 pro-5 Present address: Department of Biomedical Sciences, College of
Medicine, Florida State University, Tallahassee, Florida 32306. tein is rapidly destroyed. We show that Amn1 expression
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leads to disruption of Tem1-Cdc15 interaction in vivo nose and arrested in G1 with  factor. Cells were
released from the block into media containing galactoseand in vitro. Amn1 and Cdc15 compete for binding to
Tem1. Failure to inhibit this interaction results in disrup- to induce AMN1 expression and analyzed at different
times for budding index, spindle length, and Clb2 levels.tion of both the spindle assembly and nuclear orientation
checkpoints. The kinetics of cell cycle progression for both strains
were nearly identical until telophase. At 100 min after
release, both strains were large budded but by 140 min,Results
the cells containing vector alone had progressed into
G1 with reduced Clb2 levels while GAL-AMN1 con-A Genetic Screen for Negative Regulators
taining cells remained large budded with elongatedof the Mitotic Exit Pathway
spindles and high Clb2 levels (Figures 2A and 2B), indi-The MEN pathway acts to ensure Clb degradation
cating a delay in mitotic exit.through activation of APCCdh1. With the exception of
A defect in Clb2 destruction could be due to a defectBfa1/Bub2 (Alexandru et al., 1999l; Fraschini et al., 1999;
in Clb2 degradation directly or a defect in activation ofLi, 1999), all of MEN components act in a positive fashion
the MEN pathway. A failure to degrade Clb2 shouldto activate the pathway. To identify new negative regula-
result in an arrest with delocalized Cdc14 whereas ators of MEN, we screened for cDNAs that when overpro-
defect in MEN activation would result in nucleolarduced were lethal in a cdc5-1 mutant, which is defective
Cdc14. Thus, we examined Cdc14 localization in syn-for both the FEAR and MEN pathways. A Gal-cDNA
chronized cells overexpressing AMN1 and found thelibrary (Liu et al., 1992) was transformed into a cdc5-1
majority of telophase cells exhibited nucleolar Cdc14mutant and 12,000 transformants were selected on SC-
(Figure 2C). Thus, AMN1 interferes with MEN functionUra medium and replica-plated onto SC-Ura plates con-
prior to Cdc14 release.taining galactose at 30C, the permissive temperature
That AMN1 interferes with MEN function is furtherfor cdc5-1. Colonies that failed to grow on galactose
supported by three additional observations. First, theplates were selected. These could be either lethal alone
terminal arrest phenotype of AMN1 overexpression inor co-lethal with cdc5-1. To distinguish this, colonies
cdc5-1 mutants is a telophase arrest (Figure 1C). Sec-were mated with a wild-type strain and the resulting
ondly, CLB2 overexpression is known to be toxic in MENdiploids were tested for growth on galactose. Colonies
mutants (Jaspersen et al., 1998) and co-overexpressionthat could now grow on galactose were selected, their
of AMN1 and CLB2 results in lethality in wild-type cellsplasmids recovered and reintroduced into cdc5-1 or WT
(Figure 2D). Third, AMN1 overexpression is toxic tosic1haploids and re-examined for cdc5-1-dependent lethal-
mutants, which exhibit mitotic exit defects (Figure 2D).ity on galactose. CLB1 and a gene we have named
Antagonist of MEN, AMN1 (YBR158w), were isolated.
Amn1 contains 12 degenerate leucine-rich repeat (LRR) AMN1 Is Required for Multiple
motifs (data not shown). Overproduction of Clb2, a sub- Mitotic Checkpoints
strate of the APC is known to be toxic in cells defective Deletion of AMN1 has been reported to result in a slow
in MEN components and was used as a positive control growth phenotype in some backgrounds (Rose et al.,
for cdc5-1 toxicity (Figure 1A). We had previously iso- 1995; Ouspenski et al., 1999), although we have not
lated AMN1, then called CST13, in a screen for cDNAs observed this in the W303 background (data not shown).
that caused chromosome instability when overex- We reasoned that if AMN1 plays an inhibitory role in
pressed (Ouspenski et al., 1999). We reasoned that mitotic exit, it may display a defect when cells are ac-
Amn1 could either be a substrate of the APC that com- tively trying to prevent mitotic exit such as during spindle
petes for Clb degradation, a positive regulator of Clb assembly or nuclear orientation checkpoint arrest. We
function, a negative regulator of Cdc5, or a general nega- first examined the role of AMN1 in the nuclear orientation
tive regulator of mitotic exit. checkpoint through analysis ofact5kar9 act5-degron
Ts mutants (Hu et al., 2001). In act5 kar9 mutants,
Genetic Interactions between AMN1 and the FEAR the nucleus fails to orient and anaphase occurs within
and MEN Pathways the mother cell body (Miller and Rose, 1998), and mitotic
To determine if AMN1 overexpression lethality was spe- exit is delayed. Cells were synchronized with  factor
cific to cdc5 mutants, we examined the effects of AMN1 and released into the cell cycle at 37C. The majority of
overproduction in mutants of the MEN and FEAR path- act5-ts mutants arrested as large budded cells due to
ways. AMN1 overproduction was toxic in tem1-3, activation of the nuclear orientation checkpoint. How-
cdc15-2, dbf2-2, mob1-77, esp1-1, slk19 and, to a ever, in amn1 mutants, cells failed to maintain the arrest
lesser extent, lte1 mutants (Figure 1B and data not and 33% of the cells exited mitosis, re-entered the next
shown). AMN1 had no effect on cdc20-1 mutants (data cycle and formed a new bud (Figure 2E), indicating a
not shown). Therefore, AMN1 inhibition of cell viability checkpoint defect.
is not specific to Cdc5 dysfunction. The spindle assembly checkpoint also arrests cells
prior to mitotic exit (Hoyt et al., 1991; Li and Murray,
1991). amn1 mutants also displayed a reduced abilityAMN1 Expression Antagonizes Mitotic Exit
AMN1 expression is toxic to MEN mutants and slows to prevent mitotic exit in cultures containing 10 g/ml of
nocodazole (Figure 2F) and showed a mildly enhancedgrowth of wild-type cells. To explore Amn1’s function,
we examined if this slow growth resulted from pro- nocodazole sensitivity (Figure 2G). However, loss of
AMN1 significantly decreases the viability of bfa1 mu-longing a specific cell cycle stage. Wild-type cells con-
taining vector or GAL-AMN1 plasmid were grown in raffi- tants treated with nocodazole. Together, these results
Amn1 Inhibition of the MEN
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Figure 1. AMN1 Overexpression Is Toxic to MEN and FEAR Mutants
(A) Wild-type and cdc5-1 mutant cells containing vector, GAL-CLB2, or GAL-AMN1 plasmids were grown to saturation and 10-fold serial
dilutions were spotted onto SC media containing either glucose or galactose and incubated at room temperature for 3 days.
(B) Saturated cultures of strains with the indicated genotypes were spotted onto plates and incubated as described in (A).
(C) Wild-type and cdc5-1 mutant cells containing either vector or GAL-AMN1 plasmids were grown in SC raffinose at 25C till mid-log phase.
Galactose was then added and cultures were incubated at room temperature for 4 hr. Cells were fixed for immunofluorescence staining and
the budding index was determined. Spindle and DNA staining are shown for cdc5-1 mutants containing Gal-AMN1 grown on galactose.
indicate that AMN1 is required for multiple checkpoints pathway. Thus, we measured Amn1 accumulation in
synchronous cells lacking certain MEN components.and has overlapping functions with BFA1.
Amn1 protein failed to accumulate in cdc15 or cdc14
mutants (Figure 3C). This indicates that mitotic exit mustDaughter-Specific Cell Cycle Regulation of AMN1
Expression after Mitotic Exit occur before AMN1 is expressed and implies that the
window for Amn1 function is later than the executionDatabase analysis of AMN1 expression revealed cell
cycle regulated AMN1 mRNA levels that peak at the point of Cdc15 and Cdc14 (Figure 3C). This suggests
that Amn1 does not prevent mitotic exit but acts to turnM/G1 transition coordinately with SIC1 (Figure 3A)
(Spellman et al., 1998). We therefore examined Amn1 it off once it has functioned.
To examine the intracellular localization of Amn1, weprotein levels during the cell cycle. Amn1 was present
in G1 then was rapidly destroyed as cells entered S generated a GFP-tagged AMN1 strain and monitored
Amn1 by time lapse photography at room temperature.phase and stayed low until after anaphase (100 min).
Amn1 reaches its highest level at 120 min, when only Faint expression could be detected in the mother cell
at T  0 but high level expression was exclusively in16% of the cells displayed elongated spindles and more
than 80% of the cells were now in G1 (Figure 3B). Amn1 the daughter cell body as judged by the size of the two
cell bodies (Figure 3D, upper image). By 60 to 70 min,levels began to drop again as cells entered the second
S phase. Thus, Amn1 is cell cycle regulated and peaks the mother cell has initiated a new bud. Amn1 staining
was primarily nuclear with some cytoplasmic stainingin late M/G1.
If Amn1’s role in the cell cycle is to delay mitotic exit, using Myc-Amn1 immunofluorescence (Figure 3D, lower
image). Amn1’s daughter cell localization is likely dueits levels should increase prior to activation of the MEN
Cell
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Figure 2. Amn1 Overproduction Delays Mitotic Exit
(A) Wild-type cells with either vector or GAL-AMN1 plasmids grown in SC medium containing raffinose were arrested with  factor and released
into the cell cycle in the presence of galactose. Cells were fixed for immunofluorescence staining with anti-tubulin antibodies at the indicated
times.
(B) Amn1 overproduction results in Clb2 protein accumulation. G1 synchronized CLB2-3HA strains with vector and Gal-AMN1 were released
into medium containing galactose. Budding index was determined and protein samples were prepared every 20 min and SDS-PAGE separated
proteins were immunoblotted with anti-HA and anti-Pgk antibodies.
(C) The localization of Cdc14-HA in cells overproducing Amn1. G1 synchronized CDC14-3HA strains with vector and Gal-AMN1 were released
into medium containing galactose and prepared for immunofluorescence staining with anti-HA antibodies to quantitate Cdc14 localization.
(D) Increased Clb2 or decreased Sic1 function is toxic when Amn1 is overproduced. Cells of the indicated genotypes were grown, diluted,
and spotted as described in Figure 1A.
(E) AMN1 is required for the nuclear orientation checkpoint. kar9 act5 act5-ts (labeled act5-ts) and kar9 act5 act5-ts amn1 (labeled
act5-ts amn1) cells were synchronized with  factor and released into the cell cycle at 37C. Cell samples were collected every 30 min and
analyzed for budding index.
(F) AMN1 is required for the spindle checkpoint. Mid-log phase cells of wild-type and amn1 strains were treated with 10 g/ml of nocodazole.
Cells were collected every two hours and analyzed for budding index and the percentage of rebudded cells is shown.
(G) amn1 mutants show mild nocodazole sensitivity and enhance the nocodazole sensitivity of bfa1 mutants. Cells of the indicated genotypes
were treated as in 2F.
Amn1 Inhibition of the MEN
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Figure 3. Amn1 Is a Daughter-Specific Cell Cycle Regulated Protein
(A) Cell cycle regulated mRNA levels of SIC1 and AMN1.
(B) Amn1 protein levels are cell cycle regulated. Wild-type cells with Myc13 tagged AMN1 were synchronized with  factor and released into
the cell cycle. Protein extracts were prepared every 20 min and subjected to SDS-PAGE and immunoblotted with anti-Myc and anti-Pgk
antibodies as a control. The budding index and percentage of elongated spindles are showed in the bottom image.
(C) Amn1 protein levels fail to accumulate in cdc14-1 and cdc15-2 arrested cells. G1 arrested wild-type, cdc14-1, and cdc15-2 mutants
containing 13 Myc-tagged AMN1 were released into the cell cycle at 37C. Protein extracts were prepared every 20 min and SDS-PAGE
resolved proteins were probed with anti-Myc antibodies. The budding index is shown on the bottom image.
(D) Daughter-specific nuclear and cytoplasmic localization of Amn1-GFP. Top image: time lapse photography of Amn1-GFP fluorescence in
a live cell at ten minute intervals at 20C. Lower image: immunofluorescence and DAPI staining of Myc-Amn1 expressing cells.
(E) Amn1 requires the SCF but not the APC for its degradation. Cells of the indicated genotypes containing the GAL-AMN1 plasmid were
tested for toxicity of AMN1 expression as described in Figure 1 (top image). These cells were also arrested at G1 phase with  factor to
examine the stability of Amn1 protein (bottom image). In the presence of  factor, the cultures were shifted to 37C and galactose was added
to induce Amn1 production for 40 min. At time 0, glucose was added into the media to shut down Amn1 production. Protein samples were
prepared at indicated time after addition of glucose for immunoblotting.
to transcription as it was identified as one of eight tran- tor to the daughter nucleus (Colman-Lerner et al., 2001).
Thus, Amn1 is induced in daughter cells after executionscripts under the control of the daughter-specific tran-
scriptional program driven by Cbk1/Mob2-dependent of mitotic exit. As the daughter cell inherits the mitotic
exit apparatus that eventually becomes active, we hy-activation and localization of the Ace2 transcription fac-
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pothesize that Amn1 acts in the daughter cell to inhibit
the mitotic exit pathway once MEN has executed its
function.
Amn1 Stability Is Regulated through the SCF
During G1 and S phase, Amn1 mRNA is constant but
the Amn1 protein shows a dramatic decline as cells
enter S phase. This suggests that Amn1 might also be
subject to regulated proteolysis. Thus, we examined the
stability of Amn1 in mutants defective for the APC and
SCF E3 ligases using the standard GAL-AMN1 promoter
shutoff assay. The half-life of Amn1 in G1 arrested cells
was not affected by a cdc16-1 mutation defective for
the APC but was greatly stabilized by mutations in both
CDC53 and SKP1, indicating a role for the SCF in Amn1
degradation (Figure 3E). In addition, Amn1 overexpres-
sion was toxic in skp1-12 but not skp1-11 mutants pro-
viding further support for this possibility (Figure 3E).
Given the similarity to Sic1 in its expression pattern and
the fact that Sic1 is targeted for ubiquitination by the
SCF in a phosphorylation-dependent manner, it is possi-
ble that Amn1 is similarly regulated by Cdk1 phosphory-
lation, which would explain its rapid degradation when
cells enter S phase.
Amn1 Does Not Block MEN at the Cdc5 Step
Cdc5 promotes MEN activation in part by phosphoryla-
tion of Bfa1. To determine whether Amn1 acts to inter-
fere with MEN by blocking Cdc5 activation, we examined
the phosphorylation status of Bfa1 in cells arrested by
AMN1 overproduction. To achieve a strong telophase
arrest, we expressed AMN1 in a mob1-77 mutant. Both
mob1-77 mutant cells arrested by AMN1 overexpression
or by shifting to 37C contained fully phosphorylated
Bfa1 (Figure 4A), indicating that Amn1 affects the MEN
either downstream of Cdc5 or in a parallel pathway.
Figure 4. Tem1 Is a Dosage Suppressor of Amn1 Inhibition of MEN
Identifying the Target for Amn1-Mediated
(A) AMN1 overexpression does not inhibit Cdc5 kinase activity to-Inhibition of Mitotic Exit ward Bfa1. mob1-77 BFA1-HA strains with vector alone or the GAL-
To search for the target of Amn1-mediated MEN inhibi- AMN1 plasmid were grown in SC raffinose media at 25C to mid-
tion, we selected for genes which when overexpressed log phase. A portion of cells with the vector control was directly
shifted to 37C for 3 hr and the remaining cells were harvested atsuppress the AMN1-induced lethality of cdc5-1 mu-
0, 2, 4, and 6 hr after adding galactose for immunoblotting with anti-tants. Only one gene was isolated in this screen, TEM1
HA antibodies. The top image shows the percentage of large budded(Figure 4B). TEM1 overexpression also suppresses the
cells after addition of galactose and the bottom image shows the
slow growth phenotype caused by AMN1 overexpres- Western blot for Bfa1-HA.
sion in wild-types cells (Figure 4C). (B) TEM1 overexpression suppresses cdc5-1 lethality caused by
AMN1 overexpression. The growth of cdc5-1 mutant cells containing
the indicated combinations of Gal-TEM1 and Gal-AMN1 plasmidsAmn1 Physically Interacts with Tem1
were examined on plates containing glucose or galactose. Vector
Overproduction phenotypes often occur via titration of alone or vectors expressing unrelated cDNAs do not rescue Amn1
an interacting target protein, suggesting the possibility over-production toxicity (data not shown).
that Tem1 might interact with Amn1. To test this, protein (C) TEM1 overexpression suppresses the AMN1 overexpression
phenotype in wild-type cells. This experiment is the same as thatextracts were prepared from AMN1-MYC, TEM1-HA,
in (B), except that wild-type cells were used.and AMN1-MYC TEM1-HA strains and subjected to im-
munoprecipitation with anti-Myc or anti-HA antibodies.
We found that anti-Myc antibodies could immunopre-
in a complex and that Tem1 may be the physiologicalcipitate Tem1-HA only in the presence of Amn1-Myc
target of Amn1.(Figure 5A). Reciprocally, anti-HA antibodies could also
immunoprecipitate Amn1-Myc. We also examined the
interaction between Amn1 and other components of Amn1 Directly Binds Tem1
To determine if the Amn1-Tem1 association was direct,MEN such as Cdc5, Cdc15, Dbf2, and Mob1, and no
associations were detected (data not shown). Thus, we we examined Tem1/Amn1 binding in heterologous in-
sect cell and bacterial systems. Myc9-Tem1 and Flag-conclude that Tem1 and Amn1 are physically associated
Amn1 Inhibition of the MEN
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Amn1 were expressed alone or in combination in Sf9
cells and anti-Myc immune complexes examined by im-
munoblotting (Figure 6A). Flag-Amn1 was present in
Myc9-Tem1 immune complexes (lane 5) but was absent
when Tem1 was not expressed (lane 6). To examine
Tem1/Amn1 association in bacterial systems, His6-Tem1
was expressed by in vitro translation in E. coli extracts
in the presence of [35S]methionine and used in binding
reactions with immobilized GST-Amn1 or GST purified
from bacteria (Figure 6B). His6-Tem1 was found to asso-
ciate with GST-Amn1 (lane 3) but not GST (lane 2). In
reciprocal experiments, bacterial His6-Amn1 associated
efficiently with bacterial GST-Tem1 (lane 6) but not GST
(lane5). The LRR region of Amn1 is sufficient for Tem1
binding (data not shown). These data indicate that the
interaction between Tem1 and Amn1 is direct.
Amn1 Regulates Tem1-Cdc15 Binding
A variety of G proteins of the ras superfamily function
in part through binding and activating protein kinases
of the PAK family. Cdc15 is the PAK kinase regulated
by Tem1 (Bardin et al., 2000; Mah et al., 2001). Cdc15
binds Tem1 and this interaction is essential for its func-
tion (Asakawa et al., 2001). Cdc15/Tem1 binding is cell
cycle regulated, showing association in mitosis but not
G1 (Bardin et al., 2000). If Amn1 interferes with Tem1
after the execution of mitotic exit, then the absence
of AMN1 might allow inappropriate Tem1 function. To
explore this, we examined the association between
Tem1 and Cdc15 in amn1 mutants. In wild-type cells,
there was little association between Tem1 and Cdc15
(Figure 5B). However, in amn1 strains, Tem1 could
immunoprecipitate significant levels of Cdc15. The ab-
sence of Amn1 also increased the amount of Tem1-
Cdc15 association in G1 or M phase cells arrested by
 factor or nocodazole (Figure 5B). While consistent with
the spindle checkpoint defect, the latter observation
was surprising since Amn1 expression is low in M ar-
rested cells and is not increased in response to nocoda-
zole (data not shown). Therefore, either low levels of
Amn1 in M phase are critical or the increased Tem1-
Cdc15 association might be a result of a failure of Amn1
to act earlier in the cycle when it is more abundant.
Amn1 Can Disassemble Tem1-Cdc15 Complexes
If the absence of AMN1 promotes Tem1-Cdc15 associa-
tion, then overproducing AMN1 should interfere with
Tem1-Cdc15 association. Therefore, we examined this
association in cells overexpressing AMN1. The absence
of BFA1 is known to enhance Tem1-Cdc15 binding (Ro
et al., 2002); therefore, we performed these assays in
Figure 5. Amn1 Binds Tem1 and Regulates its Ability to Interact
a bfa1 mutant background. Strains containing GAL-
with Cdc15
(A) Amn1 physically interacts with Tem1. Cells with the indicated
genotypes were harvested and protein extracts were immunopre- (C) AMN1 overexpression inhibits the binding between Tem1 and
cipitated with anti-Myc or anti-HA antibodies, run on SDS-PAGE, Cdc15. bfa1 TEM1-13Myc CDC15-3HA cells containing vector or
and probed with Anti-HA or anti-Myc antibodies as indicated. GAL-AMN1 plasmids were grown asynchronously or arrested with
(B) Amn1 regulates the binding between Tem1 and Cdc15. AMN1  factor. Galactose was added to induce Amn1 and protein extracts
or amn1 mutants containing TEM1-13Myc CDC15-3HA were used were prepared and immunoprecipitated and immunoblotted as in (B).
in this experiment. Cycling,  factor-arrested, or nocodazole-arrested (D) AMN1 is required for timely relocalization of Cdc14 in G1. CDC14-
cells were harvested for protein extract preparation and the cell 3HA cells with AMN1 or amn1 were grown in YPD, arrested in 200
lysates were immunoprecipitated with anti-Myc antibody. Western mM HU for 3 hr, and then released into YPD containing  factor.
blots were probed with anti-HA and anti-Myc antibodies to deter- Cells were harvested at the indicated times and examined for Cdc14-
mine the amount of Tem1-Cdc15 complex formed. HA localization.
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Figure 6. Cdc15 and Amn1 Directly Bind Tem1 in a Mutually Exclusive Manner
(A) Amn1 and Tem1 interact in insect cells. Baculoviruses expressing Myc9-Tem1 and Flag-Amn1 were expressed in insect cells and anti-Myc
immune complexes (lanes 4–6) immunoblotted with anti-FLAG (top image) and anti-Myc (lower image) antibodies. Crude cell lysates (1/20th
of input) are shown in lanes 1–3.
(B) Amn1 and Tem1 interact directly. The interaction between Tem1 and Amn1 was examined using proteins produced in E. coli systems.
Immobilized GST-Amn1 (lane 3) or GST (lane 2) was used in binding reactions with Tem1 produced by in vitro translation in E. coli lysates in
the presence of [35S]methionine. Binding reactions were examined by SDS-PAGE and autoradiography. Similarly, immobilized GST-Tem1 (lane
6) or GST was using in binding reactions with radiolabeled Amn1 produced by in vitro translation in E. coli extracts. Ten percent of input
radiolabeled proteins are shown in lanes 1 and 4.
(C) Residues in Tem1 implicated in GTP binding and hydrolysis. A model of Tem1 (residues 19–141 containing the core GTPase domain) was
generated using Swiss Model with Sec4-GTP as a template. Tem1 backbone (gray ribbon), Mg2 (yellow sphere), GTP (orange), Thr-34 (pink),
Thr-52 (blue), and Asp-135 (red). Thr-34 and Thr-52 coordinate the Mg2 atom while Asp-135 makes a hydrogen bond with the guanine ring.
(D–E) Overlapping structural requirements for recognition of Tem1 by Cdc15 and Amn1. Immobilized insect cell-derived Myc9-Cdc15 (0.5 g,
see F) (D, lanes 1–4) or GST-Amn1 (1 g, see F) (E, lanes 1–4) were used in binding reactions with [35S]methionine labeled His6-Tem1 (or the
indicated Tem1 mutants) as described under Experimental Procedures. Negative controls were mock-infected insect cells subjected to anti-
Myc immunoprecipitation (D, lane 5) or GST alone (E, lanes 5–8).
(F) GST-Amn1 (lane 1) and GST (lane 2) were purified from Sf9 cells. Proteins were subjected to SDS-PAGE prior to immunoblotting with anti-
GST antibodies. Myc9-Cdc15 (lane 3) or a negative control derived from mock-infected cells were subjected to immunoprecipitation using
anti-Myc antibodies and analyzed by immunoblotting with anti-Myc antibodies.
Amn1 Inhibition of the MEN
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AMN1 or vector alone were grown in raffinose. Amn1 assays. Immobilized Myc9-Cdc15 (500 ng) was allowed
to assemble with in vitro translated Tem1 in the presencewas induced by galactose addition for 3 hr, protein ex-
tracts were prepared and coimmunoprecipitation was or absence of bacterial GST-Amn1 (0.1–1 g) or GST as
a control (Figure 6G). While Tem1 bound efficiently toexamined. Cells expressing high AMN1 levels showed
a significantly reduced Tem1-Cdc15 association (Figure Myc9-Cdc15 in the presence or absence of GST (lanes
3 and 4), increasing levels of GST-Amn1 (lanes 5–8) led5C), consistent with the AMN1 loss of function phe-
notype. to reduced levels of Tem1 association similar to that
found in control assays lacking Myc-Cdc15 (lane 2).As Amn1 is proposed to turn off Tem1 and MEN after
mitotic exit, it should be able to reverse the association Analogous competition experiments using immobilized
GST-Amn1 and purified His6-Cdc15 as competitor dem-of Tem1 and Cdc15 formed during mitotic exit. There-
fore, we examined the effects of overproduction of Amn1 onstrated that Cdc15 can also compete with Amn1 for
interaction with Tem1 (Figure 6H). Taken together, thesein G1 arrestedbfa1 cells where Tem1 is already associ-
ated with Cdc15. Raffinose grown cells containing either data indicate that Cdc15 and Amn1 interact with Tem1
in a mutually exclusive manner and are consistent withGAL-AMN1 or vector alone were arrested in G1 with 
factor, and galactose was added to induce AMN1. Cells the idea that increasing Amn1 concentrations can re-
verse signaling via the Tem1/Cdc15 complex.expressing AMN1 showed greatly reduced levels of
Cdc15 associated with Tem1 (Figure 5C). Therefore,
Amn1 has the ability to disassemble preformed Tem1-
Cdc15 complexes, turning off MEN. Discussion
If the mechanism of Amn1 is to interfere with MEN
signaling in G1 to facilitate exit from mitotic exit, then The AMEN Network Inactivates MEN
The logic of cell cycle transitions demands that whenamn1 mutants should have a defect in Cdc14 relocaliza-
tion to the nucleolus in G1. To examine this, we synchro- transitions occur, they set in motion the events neces-
sary for the next cell cycle transition. As a transitionnized cells in S phase with HU, then released from the
block into factor to examine Cdc14 relocalization. Both occurs, the new state actively inhibits the previous state
as most cell cycle states carry out mutually incompatiblewild-type and amn1 mutants showed identical rates of
delocalization of Cdc14 from the nucleolus, peaking at processes. Mitotic exit is a distinct cell cycle state char-
acterized by low Cdk1 activity and activation of an anti-100 min. However, relocalization of Cdc14 showed a 15
to 20 min delay in amn1 mutants (Figure 5D). Therefore, Cdk phosphatase Cdc14. This state is incompatible with
entry into S phase as it acts counter to Cdk1 whoseAmn1 is required for the proper timing of Cdc14 seques-
tration in G1, consistent with its role as a negative regula- activity is required for DNA synthesis. In order for cells
to prepare for the next cell cycle, they must erase thetor of Tem1 and MEN.
regulatory state involved in maintaining mitotic exit. Fail-
ure to fully reverse this state could result in a failure toAmn1 and Cdc15 Compete for Association
efficiently carryout DNA synthesis or in inappropriatewith Tem1
activation of mitotic exit. To ensure that the mitotic exitThe finding that overexpression of AMN1 in yeast re-
state is turned off after it is successfully activated, cellsduces the association of Tem1 with Cdc15 together with
activate a coordinated and multifaceted network calledthe fact that Amn1 interacts directly with Tem1 sug-
AMEN that antagonizes the MEN pathway.gested the possibility that Amn1 and Cdc15 compete
AMEN accomplishes the reversal of MEN in multiplefor association with Tem1. In vivo association of Cdc15
ways (Figure 7). First, as successfully executing mitoticwith Tem1 depends upon residues involved in GTP bind-
exit turns on APCCdh1, it necessarily leads to the destruc-ing (Asp-135) or hydrolysis (Thr-34 and Thr-52) (Asakawa
tion of Cdc5, an activator of MEN (Shirayama et al.,et al., 2001) (Figure 6C). In vitro, we found that Myc-
1998; Charles et al., 1998; Cheng et al., 1998). Cdc5 actsCdc15 (Figure 6F, lane 3) associated efficiently with
to promote mitotic exit by phosphorylating and inhibitingTem1 and Tem1T52A (Figure 6D, lanes 2 and 4) but bound
the Bfa1/Bub2 GAP complex, which maintains Tem1 inpoorly to Tem1T34A and Tem1D135A (lanes 1 and 3). To
an inactive state (Geymonat et al., 2002). A secondexamine association of these Tem1 mutants with Amn1,
means to turn off the previous state is through dephos-we performed in vitro binding assays using GST-Amn1
phorylating and presumably reactivating Bfa1/Bub2 (Hupurified from insect cells (Figure 6F, lane 1). Interest-
et al., 2001; Lee et al., 2001; Pereira et al., 2002; Yoshidaingly, the Tem1/Amn1 interaction required D135 and
et al., 2002). These events merely undo processes thatwas substantially reduced in T34 mutants (Figure 6E).
normally promote mitotic exit. However, in these studiesThese data suggest that Amn1 and Cdc15 employ over-
we have discovered a third component in which cellslapping determinants in Tem1 recognition and are con-
actually induce an inhibitor, Amn1, which actively disas-sistent with a mutually exclusive interaction. To examine
this question further, we established in vitro competition sembles the MEN signaling pathway.
(G–H) Amn1 and Cdc15 compete for association with Tem1.
(G) Myc9-Cdc15 (0.5 g, lanes 3–8) or control beads (lane 2) were incubated with 5 l Tem1 in vitro translation products that were premixed
with bacterial GST-Amn1 (0.05–1 g) or GST (1 g) as a control. In lane 4, no GST protein was added. After 60 min, washed complexes were
examined by SDS-PAGE and autoradiography. Quantitation lower image was accomplished by phosphoimager analysis.
(H) As in G except that immobilized GST-Amn1 (lanes 3–8) or GST as negative control (lane 2) from insect cells replaced Myc9-Cdc15 and
His6-Cdc15 replaced bacterial GST-Amn1.
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tially places a special burden on the daughter cells with
respect to turning off the mitotic exit machinery. Amn1
may ameliorate this potential burden as it is transcrip-
tionally induced specifically in daughter cells after mi-
totic exit. AMN1 transcription is activated by the Swi5
and Ace2 transcription factors (Colman-Lerner et al.,
2001). MEN activates these through Cdc14 activation,
which promotes Swi5 nuclear localization by dephos-
phorylation (Visintin et al., 1998). Nuclear localization of
Ace2 is dependent upon the Mob2/Cbk1 protein kinase
complex (Colman-Lerner et al., 2001). Nuclear localiza-
tion of Mob2/Cbk1 was shown to be dependent upon
Cdc14 activity (Weiss et al., 2002). Thus, MEN activates
AMN1 transcription specifically in daughter cells. While
we did not examine this, it may be the case that the
portion of amn1 mutant cells that exhibit rebudding dur-
ing checkpoint activation are derived primarily from
daughter cells.
Ensuring That Mitotic Exit Occurs Prior
to Activation of AMEN
Figure 7. A Model for How MEN Activates AMEN to Turn Off MEN If MEN induces AMEN, how does the cell ensure that
A schematic model of the genes involved in MEN and AMEN. Genes mitotic exit is completed before AMEN begins to inhibit
and arrows shown in red are involved in the AMEN pathway and it? A key event that may ensure the proper sequence
genes and arrows shown in blue are involved in the MEN pathway.
of events is the inhibition of Cdk1 activity. While Cdc14
may directly act to dephosphorylate Swi5 and to activate
Ace2, it is probable that full activation of these transcrip-
Amn1 Is a Negative Regulator of MEN Required
tion factors can only be achieved when Cdk1 activity is
for Multiple Cell Cycle Checkpoints
extinguished. This is consistent with the observation
Several lines of evidence support the conclusion that
that a CLB2 mutant lacking the destruction box arrests
Amn1 functions as a negative regulator of MEN. First,
cells in telophase (Surana et al., 1993). A second possi-
AMN1 overexpression is toxic to MEN mutants and
ble reinforcing mechanism might be stabilization of
slows growth in WT cells, resulting in arrest or delays
Amn1. Amn1 is rapidly destroyed when cells enter S
in mitotic exit and the accumulation of telophase cells
phase and its stability is regulated by the SCF, much
with high levels of Clb2 and nucleolar Cdc14. Consistent
like Sic1. It is possible that Cdk1 phosphorylation targets
with this, the AMN1 overexpression phenotype is sup-
Amn1 for degradation and that Amn1 can only accumu-
pressed by bfa1 or tab mutants, which exhibit hyperac-
late after Cdk1 activity has been inhibited. Thus, the
tive MEN (Shou and Deshaies, 2002) (data not shown).
activation of AMEN is likely to occur only after MEN has
Secondly, deletion of AMN1 leads to inappropriate mi-
achieved its goal of establishing the mitotic exit state
totic exit when the spindle assembly or nuclear orienta-
with low Cdk1 activity, thus ensuring that AMEN does
tion checkpoints are activated, marking AMN1 as a
not prematurely turn off MEN.
checkpoint gene. As Amn1 levels are low at the G2/M
transition, it forces the question of how Amn1, which is
Amn1 Acts through Inhibitionknown to function in M/G1, exerts its affects at G2/M.
of G Protein SignalingOne possibility is that the low levels of Amn1 at G2/M
Amn1 inhibits MEN in part through its ability to bind andare functionally important. A second possibility is that
inhibit Tem1 function. This is supported by the followinga failure to fully inactive MEN in G1 leads to a higher MEN
observations: (1) Tem1 overproduction can suppressactivity in G2/M. We believe that AMN1 acts coordinately
the effects of Amn1 overproduction; (2) amn1 mutantswith other checkpoint proteins to control mitotic exit
show increased activity of Tem1 as judged by the in-because double mutants between BFA1 and AMN1 are
creased association of Tem1 and Cdc15 and mitoticmore sensitive to the toxic effects of nocodazole than
checkpoint defects; (3) overexpression of Amn1 can re-either mutant alone. This is consistent with these pro-
verse the association of preformed Tem1-Cdc15 com-teins acting through different mechanisms to coordinate
plexes; and (4) Amn1 binds directly to Tem1 in vivo andexit from mitotic exit. Finally, Amn1 is required to force
in vitro and competes with Cdc15 for binding to Tem1.Cdc14 back into the nucleolus in G1. Cdc14 remains
Mutations of residues on the surface of Tem1 requireddelocalized almost twice as long in amn1 mutants.
for Cdc15 binding also interfere with Amn1 binding.
It is possible that Amn1 acts in as yet undefined ways
to promote exit from mitotic exit. For example, the S.Daughter Specificity of Amn1
An inherent asymmetry exists during budding yeast mi- pombe protein most closely related to Amn1 is Pof2,
a putative leucine-rich repeat F box protein (data nottotic exit because the components of the MEN are
greatly enriched on the spindle pole body that enters shown). F box proteins are components of SCF ubiquitin
ligase complexes and function as substrate specific re-the daughter cell as judged by immunofluorescence
(Bardin et al., 2000; Visintin and Amon, 2001). This poten- ceptors (Koepp et al., 1999). While the F box region of
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Table 1. Strains Used in This Study
Strains Genotype
Y300 MATa trp1-1 ura3-1 his3-11,3 leu2-3,112 ade2-1 can1-100
Y850 As Y300 except cdc5-1
Y2256 As Y300 except cdc16-1
Y2257 MATa tem1-3 in W303
A2003 MATa lte1::LEU2 ade2-1 leu2-3 ura3 trp1-1 his3-11,15 can1-100 GAL PSI
Y2258 As Y300 except mob1-77
K2788 MATa esp1-1 ura3 lys2 can1-100
Y2259 As Y300 except slk19::TRP1
Y2260 As Y300 except AMN1-GFP
Y2261 As Y300 except AMN1-13MYC::his5
Y2262 As Y300 except amn1::his5
Y2263 As Y300 except cdc14-1 AMN1-13MYC::his5
Y2264 As Y300 except cdc15-2 AMN1-13MYC::his5
Y552 As Y300 except skp1-11
Y2265 As Y300 except skp1-12
Y143 MATa cdc53-2 trp1-7 leu2-3,112
A1411 MATa CDC14-3HA ade2-1 leu2-3 ura3 trp1-1 his3-11,15 can1-100 GAL PSI
Y734 MATa sic1::TRP1 in W303
Y2266 CLB2-HA in W303
Y2267 As Y300 except bfa1::his5
Y2268 As Y300 except bfa1::his5 amn1::his5
Y2269 MATa kar9::KanR act5::HIS3 act5-ts-LEU2
Y2270 MATa kar9::KanR act5 ::HIS3 act5-ts-LEU2 amn1::URA3
Y2271 As Y300 except mob1-77 BFA1-3HA::TRP1
Y2272 As Y300 except TEM1-3HA::TRP1
Y2273 As Y300 except TEM1-3HA::TRP1 AMN1-13MYC::his5
KLY2614 MATa TEM1-13MYC::KanMX6 CDC15-HA::LEU2
KLY2625 MATa TEM1-13MYC::KanMX6 CDC15-HA::LEU2 bfa1::his5
Y2274 MATa TEM1-13MYC::KanMX6 CDC15-HA::LEU2 amn1::his5
Pof2 shows little conservation with Amn1, and we have orientation have occurred. Once AMEN is inactivated,
cells become permissive for MEN activation, which oc-not been able to detect association of Amn1 with Skp1
expressed in insect cells, we cannot rule out a role for curs during anaphase when the SPB-located Tem1 en-
counters its activator Lte1 in the daughter cell (BardinAmn1 in controlling the stability of proteins important
for exit from mitotic exit. A potentially relevant fact is et al., 2000). As mitotic exit is a conserved aspect of
eukaryotic cell cycles, all eukaryotes are likely to coordi-that we have observed 2- to 3-fold higher Tem1 levels
in amn1 mutants (Y.W. and S.J.E., unpublished data), nate the timing of exit from mitotic exit through regula-
tory networks like AMEN.as would be expected if Amn1 binds Tem1 and promotes
its turnover. Increased Tem1 levels could contribute to
Experimental Proceduresthe checkpoint defects observed in amn1 mutants. In
addition, a homology search has revealed a stretch of
Yeast Strains and Plasmid Construction
90 conserved amino acids (23% identical, 42% similar) All yeast strains (Table 1) are cogenic with the W303-derived Y300
between Amn1 (residues 76–167) and Lte1 (residues strain except where indicated. amn1, act5-ts act5 kar9 amn1,
743–832). This domain is not required for Amn1’s binding AMN1-13myc, AMN1-3HA, and TEM1-HA strains were made by us-
ing a PCR based method (Longtine et al., 1998). To constructto Tem1 (data not shown), but may indicate that Amn1
AMN1GFP strain, a C-terminal fragment of AMN1 as a Kpn1/Nco1competes with Lte1 for binding another factor important
fragment, was fused with EGFP in pEGFP (Clontech). The AMN1-for Lte1 function. These possibilities remain to be ex-
EGFP fusion cassette was then inserted into an integration vector
plored but may point to the possibility that Anm1 inter- pRS406 to generate plasmid pYW147. A unique HindIII site inside
feres with Tem1 function in multiple ways. the AMN1 fragment was used to linearize the plasmid and trans-
In summary, we have described a regulatory network, formed into Y300 to generate Y2260 expressing an Amn1-EGFP
fusion protein. To construct a GAL-HA-AMN1 plasmid, the AMN1AMEN, that is activated by MEN specifically in daughter
open reading frame (as a Nde1/BamH1 fragment) was ligated intocells and which coordinates exit from the mitotic exit
p1217, a CEN-TRP1-GAL-3HA vector, to generate pYW117.state of the cell cycle. This network functions in part
pYW151, a CEN-TRP1-GAL-3HA-TEM1 plasmid, was constructed
through induction of an inhibitor of G protein signaling, using a similar strategy.
Amn1, which acts directly to inhibit Tem1, reversing its
association with its key effector Cdc15 and resulting in Cytological Techniques
Tubulin staining was performed as described previously (SanchezCdc14 inhibition. We hypothesize that Cdc14 inhibition
et al., 1996). DAPI was used to visualize DNA. Amn1-EGFP localiza-allows cells to become competent for START and S
tion in log-phase cells grown in YPD was determined at 20C usingphase entry. This negative feedback loop ensures a nar-
an Applied Precision deconvolution microscope.
row window for MEN function during the cell cycle (Fig-
ure 7). AMEN itself is reversed as cells enter S phase Cell Growth Conditions
through the destruction of Amn1 and, ultimately, inacti- Synchronization in G1 was achieved by addition of  factor (10
g/ml) to mid-log phase cells followed one hour later by additionvation of Bfa1/Bub2 by Cdc5 after spindle assembly and
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of  factor (5 g/ml) for 2 hr. For spindle assembly checkpoint in budding yeast: in vitro regulation of Tem1 GTPase by Bub2 and
Bfa1. J. Biol. Chem. 277, 28439–28445.experiments, cells were treated with nocodazole (10 g/ml) prior to
cell viability measurements. Briefly, nocodazole treated cells were Hoyt, M.A., Totis, L., and Roberts, B.T. (1991). S. cerevisiae genes
sonicated, plated onto YPD plates, and incubate at 25C overnight required for cell cycle arrest in response to loss of microtubule
prior to determining the efficiency of colony formation. function. Cell 66, 507–517.
Hu, F., Wang, Y., Liu, D., Li, Y., Qin, J., and Elledge, S.J. (2001).
Protein Analysis
Regulation of the Bub2/Bfa1 GAP complex by Cdc5 and cell cycle
Yeast and insect cell extract preparation, immunoblotting, and im-
checkpoints. Cell 107, 655–665.
munoprecipitation were performed as described (Paciotti et al.,
Jaspersen, S.L., and Morgan, D.O. (2000). Cdc14 activates cdc151998; Hu et al., 2001). Monoclonal antibodies against hemagglutinin
to promote mitotic exit in budding yeast. Curr. Biol. 10, 615–618.(HA) and Myc 9E10 epitopes were from Covance while anti-Pgk was
from Molecular Probes. Baculoviruses for Cdc15, Amn1, and Tem1 Jaspersen, S.L., Charles, J.F., Tinker-Kulberg, R.L., and Morgan,
were generated using UPS (Liu et al., 1998). pET15b-based vectors D.O. (1998). A late mitotic regulatory network controlling cyclin de-
were used for translation of His6-Tem1 or His6-Amn1 in either reticu- struction in S. cerevisiae. Mol. Biol. Cell 9, 2803–2817.
locyte extracts (Promega) or in E. coli extracts (Roche) in the pres- Knapp, D., Bhoite, L., Stillman, D.J., and Nasmyth, K. (1996). The
ence of [35S]methionine. Bacterial GST-Tem1 and GST-Amn1 were transcription factor Swi5 regulates expression of the cyclin kinase
produced in BL21(DE3) cells using pET41-based vectors and puri- inhibitor p40SIC1. Mol. Cell. Biol. 16, 5701–5707.
fied using GSH-Sepharose (Pharmacia). In vitro binding assays were
Koepp, D.M., Harper, J.W., and Elledge, S.J. (1999). How the cyclinperformed using extraction buffer (50 mM Tris-HCl [pH 7.5], 150 mM
became a cyclin: regulated proteolysis in the cell cycle. Cell 97,NaCl, 1 mM EDTA, 0.1% nonidet P40, 5 mM NaF, 10 mM  glycerol
431–434.phosphate, and protease inhibitors [Roche]). His6-Cdc15 was ex-
Lee, S.E., Jensen, S., Frenz, L.M., Johnson, A.L., Fesquet, D., andpressed in Hi5 cells and purified using Nickel NTA agarose (Qiagen).
Johnston, L.H. (2001). The Bub2-dependent mitotic pathway actsFor competition experiments, in vitro translated Tem1 (5 l) was
every cell cycle and regulates cytokinesis. J. Cell Sci. 114, 2345–premixed with purified bacterial GST, GST-Amn1, or insect cell-
2354.derived His6-Cdc15 prior to performing binding reactions. Mutations
in TEM1 were generated by PCR. Li, R. (1999). Bifurcation of the mitotic checkpoint pathway in bud-
ding yeast. Proc. Natl. Acad. Sci. USA 96, 4989–4994.
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